Literature DB >> 14984256

Effect of chitosan on epithelial cell tight junctions.

Jennifer Smith1, Edward Wood, Michael Dornish.   

Abstract

PURPOSE: Chitosan has been proposed as a novel excipient for transepithelial drug-delivery systems. Chitosan is thought to disrupt intercellular tight junctions, thus increasing the permeability of an epithelium. The effect of chitosan on tight junction complex was investigated at the molecular level.
METHODS: Changes in barrier properties of Caco-2 cell monolayers, including transepithelial electrical resistance and permeability to horseradish peroxidase (HRP), were assessed in response to chitosan treatment. Changes in subcellular localization of the tight junction proteins zona occludens 1 (ZO-1) and occludin by immunofluorescence and Western blotting of cellular fractions were also assessed.
RESULTS: Chitosan was found to cause a dose-dependent reduction in transepithelial electrical resistance of Caco-2 monolayers of up to 83%. A corresponding increase in horseradish peroxidase permeability of up to 18 times greater than the control was also observed across the monolayer. Immunofluorescent localization of ZO-1 revealed loss of membrane-associated ZO-1 from discrete areas. Analysis of cellular fractions revealed a dose-dependent loss of ZO-1 and occludin from the cytosolic and membrane fractions into the cytoskeletal fraction. These changes did not occur because of chitosan-mediated ATP depletion.
CONCLUSIONS: Chitosan-mediated tight junction disruption is caused by a translocation of tight junction proteins from the membrane to the cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984256     DOI: 10.1023/b:pham.0000012150.60180.e3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Biomedical and pharmaceutical applications of alginate and chitosan.

Authors:  O Skaugrud; A Hagen; B Borgersen; M Dornish
Journal:  Biotechnol Genet Eng Rev       Date:  1999

2.  Disruption of epithelial tight junctions is prevented by cyclic nucleotide-dependent protein kinase inhibitors.

Authors:  C Klingler; U Kniesel; S D Bamforth; H Wolburg; B Engelhardt; W Risau
Journal:  Histochem Cell Biol       Date:  2000-05       Impact factor: 4.304

3.  Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia.

Authors:  S V Walsh; A M Hopkins; J Chen; S Narumiya; C A Parkos; A Nusrat
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

Review 4.  Chitosan: some pharmaceutical and biological aspects--an update.

Authors:  A K Singla; M Chawla
Journal:  J Pharm Pharmacol       Date:  2001-08       Impact factor: 3.765

Review 5.  Molecular physiology and pathophysiology of tight junctions. I. Biogenesis of tight junctions and epithelial polarity.

Authors:  M Cereijido; L Shoshani; R G Contreras
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-09       Impact factor: 4.052

6.  Effect of chitosan on epithelial permeability and structure.

Authors:  V Dodane; M Amin Khan; J R Merwin
Journal:  Int J Pharm       Date:  1999-05-10       Impact factor: 5.875

Review 7.  Molecular structure and assembly of the tight junction.

Authors:  B M Denker; S K Nigam
Journal:  Am J Physiol       Date:  1998-01

8.  Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2).

Authors:  P Artursson; T Lindmark; S S Davis; L Illum
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

9.  The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line(1).

Authors:  Giulia Ranaldi; Iolanda Marigliano; Isabella Vespignani; Giuditta Perozzi; Yula Sambuy
Journal:  J Nutr Biochem       Date:  2002-03       Impact factor: 6.048

10.  Biodegradation and distribution of water-soluble chitosan in mice.

Authors:  H Onishi; Y Machida
Journal:  Biomaterials       Date:  1999-01       Impact factor: 12.479

View more
  62 in total

1.  Recent advances in nanotechnology based drug delivery to the brain.

Authors:  Li-Na Lin; Qun Liu; Lei Song; Fang-Fang Liu; Jin-Xiu Sha
Journal:  Cytotechnology       Date:  2010-08-11       Impact factor: 2.058

2.  Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties.

Authors:  Giuseppina Sandri; Maria Cristina Bonferoni; Silvia Rossi; Franca Ferrari; Cinzia Boselli; Carla Caramella
Journal:  AAPS PharmSciTech       Date:  2010-03-16       Impact factor: 3.246

Review 3.  Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.

Authors:  Qingxing Xu; Chi-Hwa Wang; Daniel Wayne Pack
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

4.  Enhancement of nose-brain delivery of therapeutic agents for treating neurodegenerative diseases using peppermint oil.

Authors:  S R Kiran Vaka; S Narasimha Murthy
Journal:  Pharmazie       Date:  2010-09       Impact factor: 1.267

5.  Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid.

Authors:  Siva Ram Kiran Vaka; S Narasimha Murthy; Michael A Repka; Tamas Nagy
Journal:  J Pharm Sci       Date:  2011-03-01       Impact factor: 3.534

Review 6.  In vitro and in vivo models for the study of oral delivery of nanoparticles.

Authors:  Jennifer M Gamboa; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2013-02-13       Impact factor: 15.470

Review 7.  Recent advances in oral vaccine development: yeast-derived β-glucan particles.

Authors:  Rebecca De Smet; Liesbeth Allais; Claude A Cuvelier
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

8.  Planar microdevices enhance transport of large molecular weight molecules across retinal pigment epithelial cells.

Authors:  Jennifer S Wade; Tejal A Desai
Journal:  Biomed Microdevices       Date:  2014-08       Impact factor: 2.838

9.  Effect of Asparagus racemosus extract on transdermal delivery of carvedilol: a mechanistic study.

Authors:  Bharti Sapra; Subheet Jain; Ashok K Tiwary
Journal:  AAPS PharmSciTech       Date:  2009-02-24       Impact factor: 3.246

10.  Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days.

Authors:  Sara M Navarro; Caleb Darensbourg; Linda Cross; Rhett Stout; Diana Coulon; Carlos E Astete; Timothy Morgan; Cristina M Sabliov
Journal:  Ther Deliv       Date:  2014-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.